ClinicalTrials.Veeva

Menu

Benefit of Topical Hemostatic Powder Containing Hydrophilic Polymer With Potassium Ferrate for Hemostasis Following Nail Surgery

Weill Cornell Medicine (WCM) logo

Weill Cornell Medicine (WCM)

Status and phase

Withdrawn
Phase 4

Conditions

Nail Diseases

Treatments

Device: Hydrophilic polymer and potassium ferrate powder

Study type

Interventional

Funder types

Other

Identifiers

NCT04384679
20-02021562

Details and patient eligibility

About

The purpose of this study is to assess the efficacy and safety of topical hemostatic powder containing hydrophilic polymer with potassium ferrate for bleeding control after nail surgical procedures

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • At least 18 years old
  • Patients scheduled for any type of nail surgical procedure
  • Willingness to participate in the study
  • Ability to understand all instructions in the English language

Exclusion criteria

  • Failure to have nail surgery performed
  • Likely inability to comply with the study protocol or cooperate fully with the research team

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

Hydrophilic polymer and potassium ferrate powder
Experimental group
Description:
Hydrophilic polymer with potassium ferrate powder is applied to the surgical wound with pressure until hemostasis is achieved
Treatment:
Device: Hydrophilic polymer and potassium ferrate powder
Direct pressure with sterile gauze
No Intervention group
Description:
Direct pressure with sterile gauze is applied to the surgical wound until hemostasis is achieved

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems